Skip to main content

WELLS FARGO & COMPANY/MN

Position in VKTX — Viking Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in VKTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,475,732
+$527,330 QoQ
Shares Held
114,733
-5.4% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 435 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. VKTX ranks #68 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,475,732 114,733
2026-03-31 $3,948,402 121,340
2025-12-31 $9,894,867 281,264
2025-09-30 $8,213,024 312,520
2025-06-30 $4,692,301 177,068
2025-03-31 $2,305,647 95,472
2024-12-31 $10,528,190 261,635
2024-09-30 $12,173,245 192,280
2024-06-30 $5,413,750 102,127
2024-03-31 $4,941,402 60,261
2023-12-31 $535,985 28,801
2023-09-30 $1,393,456 125,877
2023-06-30 $1,627,126 100,378
2023-03-31 $1,513,401 90,895
2022-12-31 $14,137 1,504
2022-09-30 $3,258 1,198
2022-06-30 $9,279 3,211
2022-03-31 $173,526 57,842
2021-12-31 $370,336 80,508
2021-09-30 $714,920 113,841
2021-06-30 $763,087 127,394
2021-03-31 $1,211,443 191,533
2020-12-31 $1,669,079 296,462
2020-09-30 $1,433,319 246,275
2020-06-30 $1,846,768 256,140
2020-03-31 $1,061,914 226,905